These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
408 related items for PubMed ID: 27042750
1. TRABECULAR BONE SCORE CHANGE DIFFERS WITH REGARD TO 25(OH)D LEVELS IN PATIENTS TREATED FOR ADULT-ONSET GROWTH HORMONE DEFICIENCY. Kužma M, Binkley N, Bednárová A, Killinger Z, Vaňuga P, Payer J. Endocr Pract; 2016 Aug; 22(8):951-8. PubMed ID: 27042750 [Abstract] [Full Text] [Related]
2. Impact of the growth hormone replacement on bone status in growth hormone deficient adults. Kužma M, Kužmová Z, Zelinková Z, Killinger Z, Vaňuga P, Lazurová I, Tomková S, Payer J. Growth Horm IGF Res; 2014 Feb; 24(1):22-8. PubMed ID: 24382377 [Abstract] [Full Text] [Related]
3. Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender. Rota F, Savanelli MC, Tauchmanova L, Savastano S, Lombardi G, Colao A, Di Somma C. J Endocrinol Invest; 2008 Feb; 31(2):94-102. PubMed ID: 18362499 [Abstract] [Full Text] [Related]
5. Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with growth hormone deficiency (GHD): the Leiden Cohort Study. Appelman-Dijkstra NM, Claessen KM, Hamdy NA, Pereira AM, Biermasz NR. Clin Endocrinol (Oxf); 2014 Nov; 81(5):727-35. PubMed ID: 24816144 [Abstract] [Full Text] [Related]
6. The Long-Term Effects of Growth Hormone Replacement on Bone Mineral Density and Trabecular Bone Score: Results of the 10-Year Prospective Follow-up. Vaňuga P, Kužma M, Stojkovičová D, Smaha J, Jackuliak P, Killinger Z, Payer J. Physiol Res; 2021 Nov 30; 70(Suppl 1):S61-S68. PubMed ID: 35503051 [Abstract] [Full Text] [Related]
7. The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study. Drake WM, Rodríguez-Arnao J, Weaver JU, James IT, Coyte D, Spector TD, Besser GM, Monson JP. Clin Endocrinol (Oxf); 2001 Apr 30; 54(4):525-32. PubMed ID: 11318789 [Abstract] [Full Text] [Related]
8. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial. Biermasz NR, Hamdy NA, Janssen YJ, Roelfsema F. J Clin Endocrinol Metab; 2001 Jul 30; 86(7):3079-85. PubMed ID: 11443170 [Abstract] [Full Text] [Related]
9. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency. Janssen YJ, Hamdy NA, Frölich M, Roelfsema F. J Clin Endocrinol Metab; 1998 Jun 30; 83(6):2143-8. PubMed ID: 9626153 [Abstract] [Full Text] [Related]
10. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency. Götherström G, Bengtsson BA, Bosaeus I, Johannsson G, Svensson J. Eur J Endocrinol; 2007 Jan 30; 156(1):55-64. PubMed ID: 17218726 [Abstract] [Full Text] [Related]
11. Effect of growth hormone on bone status in growth hormone-deficient adults. Kuzma M, Homerova Z, Dlesk A, Koller T, Killinger Z, Vanuga P, Lazurova I, Tomkova S, Payer J. Bratisl Lek Listy; 2013 Jan 30; 114(12):689-95. PubMed ID: 24329506 [Abstract] [Full Text] [Related]
12. Effects of growth hormone (GH) replacement on bone metabolism and mineral density in adult onset of GH deficiency: results of a double-blind placebo-controlled study with open follow-up. Finkenstedt G, Gasser RW, Höfle G, Watfah C, Fridrich L. Eur J Endocrinol; 1997 Mar 30; 136(3):282-9. PubMed ID: 9100553 [Abstract] [Full Text] [Related]
13. Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiency. Elbornsson M, Götherström G, Franco C, Bengtsson BÅ, Johannsson G, Svensson J. Eur J Endocrinol; 2012 Feb 30; 166(2):181-9. PubMed ID: 22106341 [Abstract] [Full Text] [Related]
14. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. Colao A, Di Somma C, Pivonello R, Loche S, Aimaretti G, Cerbone G, Faggiano A, Corneli G, Ghigo E, Lombardi G. J Clin Endocrinol Metab; 1999 Jun 30; 84(6):1919-24. PubMed ID: 10372687 [Abstract] [Full Text] [Related]
15. Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency. Conway GS, Szarras-Czapnik M, Racz K, Keller A, Chanson P, Tauber M, Zacharin M, 1369 GHD to GHDA Transition Study Group. Eur J Endocrinol; 2009 Jun 30; 160(6):899-907. PubMed ID: 19324976 [Abstract] [Full Text] [Related]
16. Effects of discontinuation of growth hormone replacement in adult GH-deficient patients: a cohort study and a systematic review of the literature. Appelman-Dijkstra NM, Rijndorp M, Biermasz NR, Dekkers OM, Pereira AM. Eur J Endocrinol; 2016 Jun 30; 174(6):705-16. PubMed ID: 26944562 [Abstract] [Full Text] [Related]
17. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE. Yuen KCJ, Biller BMK, Radovick S, Carmichael JD, Jasim S, Pantalone KM, Hoffman AR. Endocr Pract; 2019 Nov 30; 25(11):1191-1232. PubMed ID: 31760824 [Abstract] [Full Text] [Related]
18. Does Baseline PTH Influence Recovery of Bone Mineral Density, Trabecular Bone Score and Bone Turnover Markers? A Prospective Study Following Curative PArathyroidectomy in Primary Hyperparathyroidism. Shetty S, Cherian KE, Shetty S, Kapoor N, Jebasingh FK, Cherian A, Hephzibah J, Chandramohan A, John RA, Asha HS, Paul MJ, Manipadam MT, Abraham DT, Thomas N, Paul TV. Endocr Pract; 2020 Dec 30; 26(12):1442-1450. PubMed ID: 33471736 [Abstract] [Full Text] [Related]
19. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy. Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S. J Bone Miner Res; 1998 May 30; 13(5):891-9. PubMed ID: 9610754 [Abstract] [Full Text] [Related]
20. Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism. Walker MD, Saeed I, Lee JA, Zhang C, Hans D, Lang T, Silverberg SJ. Osteoporos Int; 2016 Oct 30; 27(10):3063-71. PubMed ID: 27198233 [Abstract] [Full Text] [Related] Page: [Next] [New Search]